We are a team of multidisciplinary scientists pioneering the discovery and development of novel oral allosteric inhibitors as therapeutic agents to address unmet medical needs in oncology and chronic inflammation.
We design and develop targeted small molecule therapeutic drugs specifically designed to modulate the function of molecular mediators that play a critical role in the onset and progression of chronic inflammation and cancer.
Our trailblazing research has birthed the first-in-class oral inhibitor of IL-1β production, a small molecule that may be a game-changer in the treatment of IL-1β-related diseases that currently lack effective treatment options.
Encompassing a diverse array of cutting-edge small molecule allosteric inhibitors targeting key pathways involved in challenging diseases, our portfolio reflects our dedication to providing impactful and transformative therapies to patients in need.
https://allinky.com/wp-content/uploads/2026/04/Juan-Gomez-Reino-reconocimiento-SER.jpg
654
528
asun.burguete@allinky.com
https://allinky.com/wp-content/uploads/2024/05/Logo-Allinky-480px.png
asun.burguete@allinky.com2026-04-23 09:03:382026-04-28 09:17:07Prof. Juan Jesús Gómez-Reino recognised for a lifetime of outstanding contribution to rheumatology
https://allinky.com/wp-content/uploads/2025/01/Patente-China.jpg
515
777
asun.burguete@allinky.com
https://allinky.com/wp-content/uploads/2024/05/Logo-Allinky-480px.png
asun.burguete@allinky.com2025-01-24 11:16:372025-01-24 11:18:49Allinky secures patent grant in China
https://allinky.com/wp-content/uploads/2024/09/USPTO-news.jpg
515
777
asun.burguete@allinky.com
https://allinky.com/wp-content/uploads/2024/05/Logo-Allinky-480px.png
asun.burguete@allinky.com2024-09-06 08:18:122024-09-20 08:38:02U.S. Patent granted to Allinky
https://allinky.com/wp-content/uploads/2024/05/Presentacion-AseBio_news.jpeg.jpg
515
777
asun.burguete@allinky.com
https://allinky.com/wp-content/uploads/2024/05/Logo-Allinky-480px.png
asun.burguete@allinky.com2024-05-16 09:58:232024-09-20 08:38:11Allinky presents its inflammation program at AseBio Investor Day in San Sebastián
https://allinky.com/wp-content/uploads/2024/05/Seal-of-Excellence.jpg
515
777
asun.burguete@allinky.com
https://allinky.com/wp-content/uploads/2024/05/Logo-Allinky-480px.png
asun.burguete@allinky.com2024-03-11 09:08:092024-09-16 07:51:37Allinky is awarded a Seal of Excellence from Horizon Europe’s EIC Accelerator Program
https://allinky.com/wp-content/uploads/2023/12/03-post-EUROPEAN-PATENT-GRANTED-TO-ALLINKY.jpg
515
777
Susana Nicolau
https://allinky.com/wp-content/uploads/2024/05/Logo-Allinky-480px.png
Susana Nicolau2024-01-09 08:08:142024-09-16 08:14:05Allinky will attend AseBio Investor Day 2024
https://allinky.com/wp-content/uploads/2023/12/Patente-Europea.jpg
515
777
Susana Nicolau
https://allinky.com/wp-content/uploads/2024/05/Logo-Allinky-480px.png
Susana Nicolau2023-12-20 18:16:082024-09-16 07:52:00European patent granted to Allinky
https://allinky.com/wp-content/uploads/2023/12/02-post-ALLINKY-EXECUTES-A-NEW-CAPITAL-INCREASE-OF-2-MILLION-EUROS.jpg
515
777
Susana Nicolau
https://allinky.com/wp-content/uploads/2024/05/Logo-Allinky-480px.png
Susana Nicolau2023-12-02 18:15:552024-09-16 07:52:53Allinky executes a new capital increase of 2 million eurosPrivacy Policy Legal Notice Cookie Policy
